|
1
|
Maneechote C, Palee S, Chattipakorn SC and
Chattipakorn N: Roles of mitochondrial dynamics modulators in
cardiac ischaemia/reperfusion injury. J Cell Mol Med. 21:2643–2653.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kocman EA, Ozatik O, Sahin A, Guney T,
Kose AA, Dag I, Alatas O and Cetin C: Effects of ischemic
preconditioning protocols on skeletal muscle ischemia-reperfusion
injury. J Surg Res. 193:942–952. 2015. View Article : Google Scholar
|
|
3
|
Kunecki M, Plazak W, Podolec P and Golba
KS: Effects of endogenous cardioprotective mechanisms on
ischemia-reperfusion injury. Postepy Hig Med Dosw (Online).
71:20–31. 2017. View Article : Google Scholar
|
|
4
|
Hauerslev M, Mork SR, Pryds K, Contractor
H, Hansen J, Jespersen NR, Johnsen J, Heusch G, Kleinbongard P,
Kharbanda R, et al: Influence of long-term treatment with glyceryl
trinitrate on remote ischemic conditioning. Am J Physiol Heart Circ
Physiol. 315:H150–H158. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang C, Li H, Wang S, Mao X, Yan D, Wong
SS, Xia Z and Irwin MG: Repeated non-invasive limb ischemic
preconditioning confers cardioprotection through PKC-/STAT3
signaling in diabetic rats. Cell Physiol Biochem. 45:2107–2121.
2018. View Article : Google Scholar
|
|
6
|
Yuan Y, Cao W, Hong Y, Guo X, Wang Y, Wang
Y, Wang X and Xu P: Tilianin pretreatment prevents myocardial
ischemia-reperfusion injury via preservation of mitochondrial
function in rat heart. Phytomedicine. 34:106–114. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang Y, Zhao L and Ma J: Penehyclidine
hydrochloride preconditioning provides cardiac protection in a rat
model of myocardial ischemia/reperfusion injury via the mechanism
of mitochondrial dynamics mechanism. Eur J Pharmacol. 813:130–139.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cai XY, Lu L, Wang YN, Jin C, Zhang RY,
Zhang Q, Chen QJ and Shen WF: Association of increased S100B,
S100A6 and S100P in serum levels with acute coronary syndrome and
also with the severity of myocardial infarction in cardiac tissue
of rat models with ischemia-reperfusion injury. Atherosclerosis.
217:536–542. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wautier JL, Zoukourian C, Chappey O,
Wautier MP, Guillausseau PJ, Cao R, Hori O, Stern D and Schmidt AM:
Receptor-mediated endothelial cell dysfunction in diabetic
vasculopathy, Soluble receptor for advanced glycation end products
blocks hyperpermeability in diabetic rats. J Clin Invest.
97:238–243. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dattilo BM, Fritz G, Leclerc E, Kooi CW,
Heizmann CW and Chazin WJ: The extracellular region of the receptor
for advanced glycation end products is composed of two independent
structural units. Biochemistry. 46:6957–6970. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Raucci A, Cugusi S, Antonelli A, Barabino
SM, Monti L, Bierhaus A, Reiss K, Saftig P and Bianchi ME: A
soluble form of the receptor for advanced glycation endproducts
(RAGE) is produced by proteolytic cleavage of the membrane-bound
form by the sheddase a disintegrin and metalloprotease 10 (ADAM10).
FASEB. 22:3716–3727. 2008. View Article : Google Scholar
|
|
12
|
Yonchuk JG, Silverman EK, Bowler RP,
Agusti A, Lomas DA, Miller BE, Tal-Singer R and Mayer RJ:
Circulating soluble receptor for advanced glycation end products
(sRAGE) as a biomarker of emphysema and the RAGE axis in the lung.
Am J Respir Crit Care Med. 192:785–792. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pullerits R, Brisslert M, Jonsson IM and
Tarkowski A: Soluble receptor for advanced glycation end products
triggers a proinflammatory cytokine cascade via beta2 integrin
Mac-1. Arthritis Rheum. 54:3898–3907. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yan SF, Yan SD, Herold K, Ramsamy R and
Schmidt AM: Receptor for advanced glycation end products and the
cardiovascular complications of diabetes and beyond: Lessons from
AGEing. Endocrinol Metab Clin North Am. 35:511–524. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schmidt AM, Yan SD, Yan SF and Stern DM:
The multiligand receptor RAGE as a progression factor amplifying
immune and inflammatory responses. J Clin Invest. 108:949–955.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dang M, Zeng X, Chen B, Wang H, Li H, Du F
and Guo C: Interferon-gamma mediates the protective effects of
soluble receptor for advanced glycation end-product in myocardial
isch-emia/reperfusion. Lab Invest. 99:358–370. 2019. View Article : Google Scholar
|
|
17
|
Darwich L, Coma G, Pena R, Bellido R,
Blanco EJ, Este JA, Borras FE, Clotet B, Ruiz L, Rosell A, et al:
Secretion of interferon-gamma by human macrophages demonstrated at
the single-cell level after costimulation with interleukin (IL)-12
plus IL-18. Immunology. 126:386–393. 2009. View Article : Google Scholar :
|
|
18
|
Deng Y, Chu J, Ren Y, Fan Z, Ji X,
Mundy-Bosse B, Yuan S, Hughes T, Zhang J, Cheema B, et al: The
natural product phyllanthusmin C enhances IFN-gamma production by
human NK cells through upregulation of TLR-mediated NF-kappaB
signaling. J Immunol. 193:2994–3002. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim BR, Chun S and Cho D: Association of
neutrophil-to-lymphocyte ratio and natural killer cell activity
revealed by measurement of interferon-gamma levels in a healthy
population. J Clin Lab Anal. 33:e226402018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kang HB, Ahn KS, Oh SR and Kim JW:
Genkwadaphnin induces IFN-gamma via PKD1/NF-kappaB/STAT1 dependent
pathway in NK-92 cells. PLoS One. 9:e1151462014. View Article : Google Scholar
|
|
21
|
Pan Z, Sun X, Ren J, Li X, Gao X, Lu C,
Zhang Y, Sun H, Wang Y, Wang H, et al: miR-1 exacerbates cardiac
ischemia-reperfusion injury in mouse models. PLoS One.
7:e505152012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang BH, Wang W, Wang H, Yin J and Zeng
XJ: Promoting effects of the adipokine, apelin, on diabetic
nephropathy. PLoS One. 8:e604572013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brisslert M, Amu S and Pullerits R:
Intra-peritoneal sRAGE treatment induces alterations in cellular
distribution of CD19(+), CD3 (+) and Mac-1 (+) cells in lymphoid
organs and peritoneal cavity. Cell Tissue Res. 351:139–148. 2013.
View Article : Google Scholar
|
|
24
|
Wang Y, Wang H, Piper MG, McMaken S, Mo X,
Opalek J, Schmidt AM and Marsh CB: sRAGE induces human monocyte
survival and differentiation. J Immunol. 185:1822–1835. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ganz T: Macrophage function. New Horiz.
1:23–27. 1993.PubMed/NCBI
|
|
26
|
Ko GJ, Boo CS, Jo SK, Cho WY and Kim HK:
Macrophages contribute to the development of renal fibrosis
following ischaemia/reperfusion-induced acute kidney injury.
Nephrol Dial Transplant. 23:842–852. 2008. View Article : Google Scholar
|
|
27
|
Zhang L and Wang CC: Inflammatory response
of macrophages in infection. Hepatobiliary & pancreatic
diseases international. Hepatobiliary Pancreat Dis Int. 13:138–152.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou D, Huang C, Lin Z, Zhan S, Kong L,
Fang C and Li J: Macrophage polarization and function with emphasis
on the evolving roles of coordinated regulation of cellular
signaling pathways. Cell Signal. 26:192–197. 2014. View Article : Google Scholar
|
|
29
|
Khan MA, Assiri AM and Broering DC:
Complement and macrophage crosstalk during process of angiogenesis
in tumor progression. J Biomed Sci. 22:58–67. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Saqib U, Sarkar S, Suk K, Mohammad O, Baig
MS and Savai R: Phytochemicals as modulators of M1-M2 macrophages
in inflammation. Oncotarget. 9:17937–17950. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guo CX, Jiang X, Zeng XJ, Wang HX, Li HH,
Du FH and Chen BX: Soluble receptor for advanced glycation
end-products protects against ischemia/reperfusion-induced
myocardial apoptosis via regulating the ubiquitin proteasome
system. Free Radic Biol Med. 94:17–26. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Z, Zhou Y, Yu Y, He K and Cheng LM:
Lipopolysaccharide preconditioning increased the level of
regulatory B cells in the spleen after acute ischaemia/reperfusion
in mice. Brain Res. 1701:46–57. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu C, Zhu H, Shen R, Feng Q, Zhou H and
Zhao Z: IL-35 is a protective immunomodulator in brain ischemic
injury in mice. Neurochem Res. 43:1454–1463. 2018. View Article : Google Scholar : PubMed/NCBI
|
